Himgiri Pharma Ltd
NSE: HIMGIRIPHBSE: 514760Pharma Formulations
₹2,019.55
▲ 30.30 (+1.52%)
Key ratios
- Market cap
- ₹22,013 Cr
- Enterprise value
- ₹22,307 Cr
- 52-week range
- ₹1,496.10 – ₹2,126.30
- Day range
- ₹1,957.95 – ₹2,024.05
- P/E
- 28.36
- P/B
- 4.31
- EPS (TTM)
- ₹71.22
- Book value
- ₹468.38
- Dividend yield
- 1.09%
- ROE
- 15.75%
- ROCE
- 19.27%
- Debt / equity
- 0.14
- Interest cover
- 14.63x
- Current ratio
- 3.07
- Shares outstanding
- 10.90 Cr
- Face value
- ₹2.00
GroWiser rating
- Ownership3/5
- Valuation1/5
- Efficiency4/5
- Financials4/5
Scores (0–5) are calculated from published ratios using fixed thresholds. They describe the numbers and are not a recommendation to buy, sell or hold.
Strengths & limitations
Strengths
- Interest is covered 14.63 times by operating profit.
- Promoter shareholding is 73.59%.
Limitations
- 9.59% of promoter shares are pledged.
Generated automatically from the latest ratios using rule thresholds.
Growth (CAGR)
| 1Y | 3Y | 5Y | |
|---|---|---|---|
| Sales growth | +12.69% | +11.36% | +10.75% |
| Profit growth | +23.65% | +10.36% | +11.30% |
Compound annual growth based on annual results.
Ownership & margins
- Promoters
- 73.59%
- Pledged (promoter)
- 9.59%
- Operating margin
- 24.43%
- Net margin
- 15.14%
Peer comparison
| Company | Price | Market cap | P/E | ROE |
|---|---|---|---|---|
| Malabar Remedies | ₹3,154.80 | ₹1,91,181 Cr | 40.79 | 24.07% |
| Chambal Biotech | ₹603.25 | ₹1,50,209 Cr | 24.79 | 26.53% |
| Godavari Lifesciences | ₹883.50 | ₹28,007 Cr | 25.90 | 24.75% |
| Himgiri Pharma | ₹2,019.55 | ₹22,013 Cr | 28.36 | 15.75% |
About Himgiri Pharma
Himgiri Pharma Ltd is a fictitious company generated for demonstration. Its financial figures are sample data and do not describe any real business.
Frequently asked questions
What is the share price of Himgiri Pharma?
The share price of Himgiri Pharma was ₹2,019.55 as of 12 Nov 2026 (prices are delayed by 15 minutes).
What is the market cap of Himgiri Pharma?
The market capitalisation of Himgiri Pharma is ₹22,013 crore.
What is the P/E ratio of Himgiri Pharma?
Himgiri Pharma trades at a P/E of 28.36 based on trailing twelve-month EPS of ₹71.22.
Is Himgiri Pharma debt free?
Himgiri Pharma has a debt-to-equity ratio of 0.14.
What is the ROE of Himgiri Pharma?
Himgiri Pharma reported a return on equity of 15.75% and a return on capital employed of 19.27% in its latest financial year.
What is the promoter holding in Himgiri Pharma?
Promoters hold 73.59% of Himgiri Pharma; 9.59% of shares are pledged.